Regen Biopharma, Inc. Stock Price - RGBP

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Regen Biopharma, Inc. (QB) RGBP OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.0003 0.0003 0.0001 0.0002 0.0003 17:00:13
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
30 34,851,067 $ 0.000202 $ 7,026 26,829,799 0.0001 - 0.007
Last Trade Time Type Quantity Stock Price Currency
15:36:21 15,000 $ 0.0003 USD

Regen Biopharma, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 219.45k 731.51M $ -7.75M - - 213.90M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Regen Biopharma, Inc. News

Loading Messages....

Latest RGBP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGBP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00030.00030.00010.000230293,772,2290.000.0%
1 Month0.00040.00060.00010.000319652,136,017-0.0001-25.0%
3 Months0.0010.00190.00010.00052926,540,932-0.0007-70.0%
6 Months0.0010.00290.00010.000830319,989,773-0.0007-70.0%
1 Year0.00420.0070.00010.001161414,802,500-0.0039-92.86%
3 Years0.090.127720.00010.00230065,295,252-0.0897-99.67%
5 Years0.120.4480.00010.00442543,224,214-0.1197-99.75%

Regen Biopharma, Inc. Description

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.